GE HealthCare debuts AI suite for early breast cancer detection
GE HealthCare introduced a suite of new artificial intelligence (AI) applications to streamline radiologist workflows and enhance early detection of breast cancer. The system was unveiled at the Radiological Society of North America (RSNA) 2023 annual meeting in Chicago.
The MyBreastAI suite integrates three applications designed by iCAD, an AI company that specializes in developing software to support the early detection of cancer, as well as the development of care plans through clinical support.
In its announcement, GE HealthCare said the suite is designed to aid radiologists in the reading of mammograms, improving accuracy while saving them time. According to the company, the suite should be particularly useful for making breast density assessments, which the AI can do automatically.
The suite's applications have shown promising results in clinical settings, with studies indicating an 8% increase in reader sensitivity, a 6.9% increase in reader specificity, and up to a 52% decrease in reading time.
MyBreastAI is FDA cleared and available in the U.S.
Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.